| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10598352 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Abstract
Investigation of weak screening hits led to the identification of N-alkyl-N-[1-(3,3-diphenylpropyl)piperidin-4-yl]-2-phenylacetamides and N-alkyl-N-[1-(3,3-diphenylpropyl)piperidin-4-yl]-Nâ²-benzylureas as potent, selective ligands for the human CCR5 chemokine receptor.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jeremy N. Burrows, John G. Cumming, Shaun M. Fillery, Gordon A. Hamlin, Julian A. Hudson, Ruth J. Jackson, Sharon McLaughlin, John S. Shaw,